US Patent Issued to NATIONAL HEALTH RESEARCH INSTITUTES on Oct. 6 for "Lipidated FLIPr and uses thereof in vaccine" (Taiwanese Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,752,003, issued on Oct. 6, was assigned to NATIONAL HEALTH RESEARCH INSTITUTES (Miaoli County, Taiwan).

"Lipidated FLIPr and uses thereof in vaccine" was invented by Hsin-Wei Chen (Miaoli County, Taiwan), Ming-Shu Hsieh (Miaoli County, Taiwan), Shih-Jen Liu (Miaoli County, Taiwan) and Ching-Len Liao (Miaoli County, Taiwan).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to a vaccine composition, comprising a recombinant lipidated FLIPr (rLF), and the use thereof in enhancing humoral and cellular immune responses. The recombinant lipidated FLIPr of present invention may be used as a vaccine candidate that can induce anti-FLIPr...